Apr 24 |
Avenue Therapeutics Announces Reverse Stock Split
|
Apr 11 |
3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024
|
Mar 28 |
Fortress Biotech GAAP EPS of -$8.47 beats by $0.64, revenue of $84.51M beats by $4.83M
|
Mar 28 |
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
|
Mar 28 |
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
|
Mar 25 |
Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
|
Mar 22 |
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
|
Mar 21 |
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
|
Mar 19 |
Journey Medical announces U.S. FDA acceptance of NDA for its rosacea treatment
|
Mar 18 |
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
|